HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats

References

• Vendemiale G, Grattagliano I, Portincasa P, Serviddio G, Palasciamo G, Altomare E. Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up. Eur J Clin Invest 2001;31:54–63.
   PubMedGoogle Scholar
• Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T, Yorifuji T, Asayama K, Katayama S, Uemoto S, Kobayashi K, Takayanagi M, Fujisawa T, Tsukahara H. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 2006;60:472–477.
   PubMed Web of Science ®Google Scholar
• Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 2006;387:349–360.
   PubMed Web of Science ®Google Scholar
• Wang T, Weinman SA. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J Gastroenterol Hepatol 2006;21(Suppl 3):S34–S37.
   Google Scholar
• Farber E. Some emerging general principles in the pathogen-esis of hepatocellular carcinoma. Cancer Surv 1986;5:695–718.
   PubMedGoogle Scholar
• Trueba GP, Sanchez GM, Giuliani A. Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci 2004;9:2029–2044.
   PubMed Web of Science ®Google Scholar
• Anisimov VN. Biology of aging and cancer. Cancer Control 2007;14:23–31.
   PubMedGoogle Scholar
• Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239–267.
   PubMed Web of Science ®Google Scholar
• Pitot HC, Dragan YP, Teeguarden J, Hsia S, Campbell H. Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol 1996;24:119–128.
   PubMed Web of Science ®Google Scholar
• Dragan YP, Campbell HA, Baker K, Vaughan J, Mass M, Pitot HC. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis 1994;15:2587–2591.
   PubMed Web of Science ®Google Scholar
• Laconi E, Pani P, Farber E. The resistance phenotype in the development and treatment of cancer. Lancet Oncol 2000; 1:235–241.
   PubMedGoogle Scholar
• McGlynn KA, London WT Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:3–23.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576.
   PubMed Web of Science ®Google Scholar
• Mori M, Hattori A, Sawaki M, Tsuzuki N, Sawada N, Oyamada M, Sugawara N, Enomoto K. The LEC rat: a model for human hepatitis, liver cancer, and much more. Am J Pathol 1994;144:200–204.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Miyane K, Hirooka T, Endoh D, Higuchi H, Nagahata H, Nakayama K, Kon Y, Okui T. Inhibitory effects of trientine, a copper-chelating agent, on induction of DNA strand breaks in hepatic cells of Long-Evans Cinnamon rats. Biochim Biophys Acta 2004;1674:312–318.
   PubMed Web of Science ®Google Scholar
• Jong-Hon K, Togashi Y, Kasai H, Hosokawa M, Takeichi N. Prevention of spontaneous hepatocellular carcinoma in Long-Evans cinnamon rats with hereditary hepatitis by the administration of D-penicillamine. Hepatology 1993;18:614–620.
   PubMed Web of Science ®Google Scholar
• Nair J, Strand S, Frank N, Knauft J, Wesch H, Galle PR, Bartsch H. Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis 2005;26:1307–1315.
   PubMed Web of Science ®Google Scholar
• Nair J, Sone H, Nagao M, Barbin A, Bartsch H. Copper-dependent formation of miscoding etheno-DNA adducts in the liver of Long Evans cinnamon (LEC) rats developing hereditary hepatitis and hepatocellular carcinoma. Cancer Res 1996;56:1267–1271.
   PubMed Web of Science ®Google Scholar
• Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170–1173.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 1995;275:94–100.
   PubMed Web of Science ®Google Scholar
• Borovic S, Rabuzin F, Waeg G, Zarkovic N. Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic Res 2006;40:809–820.
   PubMed Web of Science ®Google Scholar
• Waeg G, Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 1996;25:149–159.
   PubMed Web of Science ®Google Scholar
• Zarkovic N. 4-hydroxynonenal as a bioactive marker of patho-physiological processes. Mol Aspects Med 2003;24:281–291.
   PubMedGoogle Scholar
• Zivkovic M, Zarkovic K, Skrinjar L, Waeg G, Poljak-Blazi M, Borovic-Sunjic S, Shaur R, Zarkovic N. A new method for detection of HNE-histidine conjugates in rat inflammatory cells. Croat Chem Acta 2005;78:91–98.
   Web of Science ®Google Scholar
• Yelisyeyeva O, Cherkas A, Zarkovic K, Semen K, Kaminskyy D, Waeg G, Zarkovic N. The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic Res 2008;42:205–211.
   PubMed Web of Science ®Google Scholar
• Gveric-Ahmetasevic S, Sunjic SB, Skala H, Andrisic L, Stroser M, Zarkovic K, Skrablin S, Tatzber F, Cipak A, Jaganjac M, Waeg G, Gveric T, Zarkovic N. Oxidative stress in small-forgestational age (SGA) term newborns and their mothers. Free Radic Res 2009;43:376–384.
   PubMed Web of Science ®Google Scholar
• Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem 1969;17:517–526.
   PubMed Web of Science ®Google Scholar
• Marquez-Quinones A, Paris A, Roussel B, Perez-Carreon J, Le Berre V, Francois JM, Villa-Trevino S, Gueraud F. Protea-some activity deregulation in LEC rat hepatitis: following the insights of transcriptomic analysis. Omics 2007;11:367–384.
   PubMedGoogle Scholar
• Kasai N, Osanai T, Miyoshi I, Kamimura E, Yoshida MC, Dempo K. Clinico-pathological studies of LEC rats with hereditary hepatitis and hepatoma in the acute phase of hepatitis. Lab Anim Sci 1990;40:502–505.
   PubMedGoogle Scholar
• Sawaki M, Enomoto K, Takahashi H, Nakajima Y, Mori M. Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis 1990;11:1857–1861.
   PubMed Web of Science ®Google Scholar
• Jain S, Suzuki K, Jain S, Sugiyama T, Taniguchi N. Hypomethilation-associated expression of cytochrome P-450 and γ-glutamyl transpeptidase during hereditary hepatocarcino-genesis in LEC rats. Taniguchi N. The LEC rat. New York: Springer-Verlag; 1992. 162–168.
   Google Scholar
• Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashina A. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189:198–205.
   PubMed Web of Science ®Google Scholar
• Paolicchi A, Marchi S, Petruccelli S, Ciancia E, Malvaldi G, Pompella A. Gamma-glutamyltransferase in fine-needle liver biopsies of subjects with chronic hepatitis C. J Viral Hepat 2005;12:269–273.
   PubMedGoogle Scholar
• Aliya S, Reddanna P, Thyagaraju K. Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer? Mol Cell Biochem 2003;253:319–327.
   PubMedGoogle Scholar
• Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985;82:3964–3968.
   PubMed Web of Science ®Google Scholar
• Sakai M, Muramatsu M. Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis. Biochem Biophys Res Commun 2007;357:575–578.
   PubMed Web of Science ®Google Scholar
• Fukuda A, Nakamura Y, Ohigashi H, Osawa T, Uchida K. Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal. Biochem Biophys Res Commun 1997;236:505–509.
   PubMed Web of Science ®Google Scholar
• Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003;24:167–175.
   PubMedGoogle Scholar
• Poli G, Biasi F, Leonarduzzi G. 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 2008;29:67–71.
   PubMed Web of Science ®Google Scholar
• Feng Z, Hu W, Tang MS. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 2004;101:8598–8602.
   PubMed Web of Science ®Google Scholar
• Long EK, Murphy TC, Leiphon LJ, Watt J, Morrow JD, Milne GL, Howard JR, Picklo MJ, Sr. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J Neurochem 2008;105:714–724.
   PubMed Web of Science ®Google Scholar
• Zarkovic K, Uchida K, Kolenc D, Hlupic L, Zarkovic N. Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res 2006;40:543–552.
   PubMed Web of Science ®Google Scholar
• Parola M, Robino G, Marra F, Pinzani M, Bellomo G, Leonarduzzi G, Chiarugi P, Camandola S, Poli G, Waeg G, Gentilini P, Dianzani MU. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 1998;102:1942–1950.
   PubMed Web of Science ®Google Scholar
• Sharma R, Sharma A, Dwivedi S, Zimniak P, Awasthi S, Awasthi YC. 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochemistry 2008;47:143–156.
   PubMed Web of Science ®Google Scholar
• Wacker M, Schuler D, Wanek P, Eder E. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol 2000;13:1165–1173.
   PubMed Web of Science ®Google Scholar
• Togashi Y, Li Y, Kang JH, Takeichi N, Fujioka Y, Nagashima K, Kobayashi H. D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. Hepatology 1992;15:82–87.
   PubMedGoogle Scholar
• Klein D, Lichtmannegger J, Heinzmann U, Summer KH. Dissolution of copper-rich granules in hepatic lysosomes by D-penicillamine prevents the development of fulminant hepatitis in Long-Evans cinnamon rats. J Hepatol 2000;32:193–201.
   PubMed Web of Science ®Google Scholar